-+ 0.00%
-+ 0.00%
-+ 0.00%
Heights Capital trims Faron Pharmaceuticals stake to 19.96% voting rights
Share
Listen to the news
Heights Capital trims Faron Pharmaceuticals stake to 19.96% voting rights
  • Heights Capital Management cut its total stake in Faron Pharmaceuticals to 19.96% on Sept. 14, from 20.25%.
  • Share voting rights fell to 8.66%, from 8.95%.
  • Voting rights via convertible bonds stayed at 11.3%.
  • Total voting rights held were 45,495,191.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Faron Pharmaceuticals Oyj published the original content used to generate this news brief on September 17, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending